Cardio oncology is the branch of cardiology that deals with the early diagnosis, ongoing surveillance, and therapeutic management of cardiovascular conditions brought on by chemotherapeutic and radiotherapeutic side effects. Cardiovascular dysfunction, a major source of morbidity and mortality in the oncologic population, can be brought on by either cancer treatment method.
Nuclear Cardiology:
Nuclear cardiology is a branch of general cardiology that focuses on the assessment, diagnosis, and treatment of cardiac problems using radioactive materials and imaging methods. Non-invasive methods are used in nuclear cardiology studies to visualise the magnitude and location of a heart attack as well as analyse myocardial blood flow and the heart's ability to pump blood. Close monitoring is crucial for patients who developed cardiac conditions like heart failure, preeclampsia, cardiomyopathy, coronary events, or arrhythmia while pregnant. The following list of popular nuclear cardiology methods includes:
Title : Managing total chronic coronary occlusion: Noninvasive External Counterpulsation (ECP) induces collaterogenesis, relieving ischemia, as demonstrated by quantitative PET myocardial perfusion imaging: ECP is a cost-effective alternative to high risk PCI
Michael E Merhige, State University of NY at Buffalo, United States
Title : Effects of impaired microcirculation in the musculoskeletal system
Roger H Coletti, Interventional Health, PA, United States
Title : Dopamine D2 receptor and inverse salt sensitivity
Pedro A Jose, The George Washington University of School of Medicine & Health Sciences, United States
Title : Novel signaling pathways and therapeutic options for pulmonary hypertension
Yong Xiao Wang, Albany Medical Center, United States
Title : Precision medicine for a personalized care in dyslipidaemia
Syed Raza, Awali Hospital, Bahrain
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model to be set up through biodesign-inspired and biotech-driven translational applications and cardiology-related marketing to secure the human healthcare and biosafety
Sergey Suchkov, Institute for Biotech & Global Health of RosBiotech and A.I. Evdokimov MGMSU, Russian Federation